kneat.com, inc. (TSE:KSI – Free Report) – Stifel Canada lifted their FY2024 earnings per share estimates for shares of kneat.com in a research report issued to clients and investors on Tuesday, November 12th. Stifel Canada analyst J. Keywood now forecasts that the company will post earnings of ($0.13) per share for the year, up from their prior estimate of ($0.15). The consensus estimate for kneat.com’s current full-year earnings is ($0.12) per share. Stifel Canada also issued estimates for kneat.com’s Q4 2024 earnings at ($0.03) EPS and FY2025 earnings at ($0.11) EPS.
A number of other brokerages also recently weighed in on KSI. Cibc World Mkts upgraded kneat.com to a “strong-buy” rating in a report on Tuesday, October 29th. Ventum Cap Mkts raised shares of kneat.com to a “strong-buy” rating in a research note on Wednesday, August 7th. Finally, CIBC set a C$6.00 price objective on kneat.com and gave the company an “outperform” rating in a research report on Tuesday, October 29th.
kneat.com Price Performance
Shares of TSE:KSI opened at C$5.00 on Friday. The company has a market capitalization of C$430 million, a PE ratio of -31.25, a price-to-earnings-growth ratio of 597.67 and a beta of 1.08. The company has a debt-to-equity ratio of 95.14, a quick ratio of 1.50 and a current ratio of 1.47. The stock has a fifty day moving average of C$4.78 and a 200-day moving average of C$4.53. kneat.com has a one year low of C$2.80 and a one year high of C$5.17.
About kneat.com
kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries.
See Also
- Five stocks we like better than kneat.com
- What is the NASDAQ Stock Exchange?
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Top-Performing Non-Leveraged ETFs This Year
- ETF Screener: Uses and Step-by-Step Guide
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for kneat.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for kneat.com and related companies with MarketBeat.com's FREE daily email newsletter.